Scientists have developed a new nanotechnology tool, which can become a new way of testing blood to bring information about cancer. A report of which has been given by the University of Manchester. It has been reported that minimally invasive blood tests have the ability to detect and monitor life-threatening diseases such as cancer, but it is difficult to identify the indicators of diseases in the bloodstream, as they are very small and very rare. For this reason researchers at the University of Manchester have conducted a research that found that small molecules in the body of cancer patients, especially proteins, stick to nanoparticles during blood flow.
A report of which has been given by the University of Manchester.
Sticking to the nanoparticles from the blood can analyze glued molecules, some of which are released from growing cancer. Meanwhile, Manchester researcher Professor Kostas Kostarellos said that “we want to increase the signs of cancer in the blood, which can be buried in the other way among the molluscular noise”. He also added, “Our team hopes to find a team of biomolecules that can warn early in cancer, which can form the basis for detection in a new trial.” It is being told that this research has been published in the journal Advanced Materials.